The present invention provides BoNT/A peptides as well as methods of predicting or determining immunoresistance to botulinum toxin therapy in an individual using BoNT/A peptides.

 
Web www.patentalert.com

< Medicament, in particular for the treatment of diabetes mellitus type 2

> Moringa crude extracts and their derived fractions with antifungal activities
~ 00482